Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10087048rdf:typepubmed:Citationlld:pubmed
pubmed-article:10087048lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:10087048lifeskim:mentionsumls-concept:C0034830lld:lifeskim
pubmed-article:10087048lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:10087048lifeskim:mentionsumls-concept:C1533157lld:lifeskim
pubmed-article:10087048lifeskim:mentionsumls-concept:C0439098lld:lifeskim
pubmed-article:10087048pubmed:issue1lld:pubmed
pubmed-article:10087048pubmed:dateCreated1999-4-21lld:pubmed
pubmed-article:10087048pubmed:abstractTextNeonatal mice resist the lethal effect of Waglerin-1. Because Waglerin-1 blocks the nicotinic acetylcholine receptor of mature end-plates, the appearance of lethality may result from the epsilon- for gamma-subunit substitution. In support of this hypothesis, adult knockout (KO) mice lacking the gene coding for the epsilon-subunit resist the lethal effect of Waglerin-1. In contrast, heterozygous litter mates respond to Waglerin-1 like adult wild-type mice. In vitro application of 1 microM Waglerin-1 inhibited spontaneous miniature end-plate potentials and evoked end-plate potentials of adult wild-type and heterozygous KO mice. Both miniature end-plate potentials and end-plate potentials of neonatal wild-type and adult homozygous KO mice resisted Waglerin-1. Waglerin-1 decreased the end-plate response of adult wild-type mice to iontophoretically applied acetylcholine (ACh) with an IC50 value of 50 nM; 1 microM Waglerin-1 decreased the ACh response to 4 +/- 1% of control for adult heterozygous KO mice. In contrast, 1 microM Waglerin-1 decreased the ACh response to 73 +/- 2% of control for wild-type mice less than 11 days old and had no effect on the ACh response of adult homozygous KO mice. Between 11 and 12 days after birth, the suppressant effect of Waglerin-1 on wild-type end-plate responses to ACh dramatically increased. Waglerin-1 reduced binding of alpha-bungarotoxin to end-plates of adult but not neonatal wild-type mice. These data demonstrate that Waglerin-1 selectively blocks the mouse muscle nicotinic acetylcholine receptor containing the epsilon-subunit.lld:pubmed
pubmed-article:10087048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:languageenglld:pubmed
pubmed-article:10087048pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:citationSubsetIMlld:pubmed
pubmed-article:10087048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10087048pubmed:statusMEDLINElld:pubmed
pubmed-article:10087048pubmed:monthAprlld:pubmed
pubmed-article:10087048pubmed:issn0022-3565lld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:SchmidtJ JJJlld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:SchwarzHHlld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:LentzT LTLlld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:WitzemannVVlld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:WeinsteinS...lld:pubmed
pubmed-article:10087048pubmed:authorpubmed-author:McArdleJ JJJlld:pubmed
pubmed-article:10087048pubmed:issnTypePrintlld:pubmed
pubmed-article:10087048pubmed:volume289lld:pubmed
pubmed-article:10087048pubmed:ownerNLMlld:pubmed
pubmed-article:10087048pubmed:authorsCompleteYlld:pubmed
pubmed-article:10087048pubmed:pagination543-50lld:pubmed
pubmed-article:10087048pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:meshHeadingpubmed-meshheading:10087048...lld:pubmed
pubmed-article:10087048pubmed:year1999lld:pubmed
pubmed-article:10087048pubmed:articleTitleWaglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.lld:pubmed
pubmed-article:10087048pubmed:affiliationDepartment of Pharmacology and Physiology, New Jersey Medical School, Newark, USA.lld:pubmed
pubmed-article:10087048pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10087048pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:10087048pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10087048pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11448entrezgene:pubmedpubmed-article:10087048lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10087048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10087048lld:pubmed